Pre-Implant Outcome Predictors in Patients With Refractory Cardiogenic Shock Supported With VA-ECMO

Cardiogenic shock complicates acute myocardial infarction, cardiac surgery, and decompensated heart failure of other etiologies, and has an in-hospital mortality rate ranging widely from 40% to 90%. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) offers acute temporary life support to